Back to Search
ALEXANDRA TEE, MD
MD
Family Medicine Physician
NPI: 1881198406IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A164392(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Bench-to-bedside review: The MET syndrome--the challenges of researching and adopting medical emergency teams.
PMID 18254927·Crit Care·2008
6-review
Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1.
PMID 16098514·FEBS Lett·2005
8-other
Characterizing the interaction of the mammalian eIF4E-related protein 4EHP with 4E-BP1.
PMID 15094042·FEBS Lett·2004
7-preclinical
Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin.
PMID 12867426·J Biol Chem·2003
8-other
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.
PMID 12906785·Curr Biol·2003
4-observational
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
PMID 12271141·Proc Natl Acad Sci U S A·2002
8-other
Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif.
PMID 11865047·Mol Cell Biol·2002
7-preclinical
Staurosporine inhibits phosphorylation of translational regulators linked to mTOR.
PMID 11526437·Cell Death Differ·2001
7-preclinical
DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling.
PMID 10871854·Oncogene·2000
7-preclinical
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition.
PMID 19272448·Cell Signal·2009
7-preclinical
Tertiary active transport of amino acids reconstituted by coexpression of System A and L transporters in Xenopus oocytes.
PMID 19622785·Am J Physiol Endocrinol Metab·2009
7-preclinical
Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
PMID 19342222·Eur J Cancer·2009
7-preclinical
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.
PMID 19166929·Cell Signal·2009
6-review
Advances in lung cancer diagnosis and staging: endobronchial ultrasound.
PMID 17916175·Intern Med J·2008
4-observational
A prospective study of factors influencing the outcome of patients after a Medical Emergency Team review.
PMID 18651130·Intensive Care Med·2008
8-other
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis.
PMID 18003922·Proc Natl Acad Sci U S A·2007
7-preclinical
Enhancing the anti-angiogenic action of histone deacetylase inhibitors.
PMID 17958916·Mol Cancer·2007
7-preclinical
EUS-FNA of the left adrenal gland is safe and useful.
PMID 18071608·Ann Acad Med Singap·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1200 EL CAMINO REAL
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 742-2000
Quick Facts
- NPI
- 1881198406
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile